Nilotinib

ATC L01EA03 · 11 markets · 119 records

Nilotinib 11 markets · 119 records Forms

US 28 records · 7 strengths

  • 150 mgcapsuleTasignaManufacturer: Apotex Corp.、Manufacturer: AvKARE、Manufacturer: Camber Pharmaceuticals, Inc.、Manufacturer: Cipla USA Inc.、Manufacturer: Dr. Reddy's Laboratories Inc、Manufacturer: Novadoz Pharmaceuticals LLC、Manufacturer: Novartis Pharma Stein AG、Manufacturer: Torrent Pharmaceuticals Lim… also in FR·AU·CN +4
  • 200 mgcapsuleTasignaManufacturer: Apotex Corp.、Manufacturer: AvKARE、Manufacturer: Camber Pharmaceuticals, Inc.、Manufacturer: Cipla USA Inc.、Manufacturer: Dr. Reddy's Laboratories Inc、Manufacturer: Novadoz Pharmaceuticals LLC、Manufacturer: Novartis Pharma Stein AG、Manufacturer: Torrent Pharmaceuticals Lim… also in FR·AU·CN +3
  • 50 mgcapsuleTasignaManufacturer: Apotex Corp.、Manufacturer: Cipla USA Inc.、Manufacturer: Dr. Reddy's Laboratories Inc、Manufacturer: Novadoz Pharmaceuticals LLC、Manufacturer: Novartis Pharma Stein AG also in CN·ES·GB +2
  • 95 mgtabletDANZITEN
  • 80 mgtabletCAVHANZA
  • 71 mgtabletDANZITEN
  • 60 mgtabletCAVHANZA

FR 16 records · 4 strengths

11 records · 0 manufacturers 11 registros · 0 fabricantes 11 个记录 · 0 个厂家 11 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名NILOTINIB BIOGARAN 150 mg, gélule ×4NILOTINIB EG 150 mg, gélule ×4NILOTINIB TEVA 150 mg, gélule ×4NILOTINIB VIATRIS 150 mg, gélule ×9TASIGNA 150 mg, gélule ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

AU 15 records · 5 strengths

  • 150 mgcapsuleCeahaniMSN-NILOTINIB、NILOTAS、Tasigna also in US·FR·CN +4
  • 200 mgcapsuleCeahaniMSN-NILOTINIB、NILOTAS、Tasigna also in US·FR·CN +3
  • 227.38 mgcapsuleNILOTINIB-TEVA nilotinib (as hydrochloride) 150 mg capsule blister pack unknown
  • 170.54 mgcapsuleNILOTINIB-TEVA nilotinib (as hydrochloride) 150 mg capsule blister pack unknown
5 records · 0 manufacturers 5 registros · 0 fabricantes 5 个记录 · 0 个厂家 5 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Ceahani ×1MSN-NILOTINIB ×1NILOTAS ×1NILOTINIB VIATRIS ×1Tasigna ×16

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

CN 15 records · 3 strengths

  • 150 mgcapsule达希纳尼洛替尼Manufacturer: 苏州特瑞药业股份有限公司、Manufacturer: 齐鲁制药有限公司 also in US·FR·AU +4
  • 200 mgcapsule达希纳尼洛替尼Manufacturer: 苏州特瑞药业股份有限公司、Manufacturer: 齐鲁制药有限公司 also in US·FR·AU +3
  • 50 mgcapsule达希纳尼洛替尼 also in US·ES·GB +2

ES 11 records · 3 strengths

GB 9 records · 3 strengths

  • 150 mgcapsuleTasignaManufacturer: Accord-UK Ltd、Manufacturer: Teva UK Ltd、Manufacturer: Zentiva Pharma UK Ltd also in US·FR·AU +4
  • 200 mgcapsuleTasignaManufacturer: Accord-UK Ltd、Manufacturer: Teva UK Ltd、Manufacturer: Zentiva Pharma UK Ltd also in US·FR·AU +3
  • 50 mgcapsuleTasigna also in US·CN·ES +2

CA 9 records · 3 strengths

HK 4 records · 1 strengths

    4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名APO-NILOTINIB HARD CAPSULES 150MG ×4Tasigna ×16

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    SG 2 records · 2 strengths

    EU 2 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
      With a brand name Con nombre comercial 有商品名 有商品名NILOTINIB ACCORD ×2Tasigna ×8

      Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

      Also called: 尼罗替尼 nickname

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

      A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.